eFT226 (zotatifin)
first-in-class eIF4A RNA helicase inhibitor in clinical dev. for solid tumors (Ph. I, IV QW) from optimization of a natural product J. Med. Chem., May 29, 2020 eFFECTOR Therapeutics, San Diego, CA
Molecules of the Month - May 2020
Molecules of the Month
- eFT226 (zotatifin)
- DS-1971a
- BMS-986235/LAR-1219
- JNJ-54717793
- “compound 34”
- GNE-149
- [18F]LSN3316612
- RO7185876
- ONO-8430506
- "compound 15"
- NLG802
- “compound 6g”
- GSK232
- LEI401